Re:Blood Oxygen Monitoring Returning to Apple Watch in the US
by realityking on Friday August 15, 2025 @07:29AM
(#44911031)
Absolutely. But if the new company pays them to just recreate the IP the developed in the previous company - now much faster because they‘ve done it before - that‘s an issue. And patents protect against that.
That said, a patent whose primary claim seems to be (based on the workaround) _where_ the processing takes place (ant not _how_) seems like exactly the kinda thing that shouldn‘t be patentable.
If Masimo wanted to, they'd have offered them the same or more to keep them, but they didn't. I don't believe an employer has any right to expect other companies not to offer positions to their employees. Employees should not be kept in the dark on opportunities for better pay and conditions because you can't or don't want to fight that offer.